Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Jun;215(6):598–605. doi: 10.1097/00000658-199206000-00006

The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation.

A Shaked 1, J O Colonna 1, L Goldstein 1, R W Busuttil 1
PMCID: PMC1242511  PMID: 1632681

Abstract

Thirty-six patients underwent orthotopic liver transplantation (OLT) for primary sclerosing cholangitis under cyclosporine, azathioprine, and steroid immunosuppression. Of these patients, 29 suffered from chronic ulcerative colitis. The purpose of this study is to determine (1) whether replacement of the diseased liver and the altered immunocompetence suppresses the manifestation of chronic ulcerative colitis, and (2) if active colonic disease alters allograft function. Thirty of 36 patients survived OLT. After OLT, seven of 14 patients with symptomatic colon disease at the time of transplantation continue to suffer from active chronic ulcerative colitis, and three of 13 who were asymptomatic developed clinically active disease. Intractable colonic disease was the indication for post-OLT proctocolectomy in three patients, and one refused an indicated colectomy. Despite the long duration of the disease, none developed colonic malignancy. Long-term graft assessment showed good hepatocyte synthetic function in patients suffering from either active or inactive disease. Liver alkaline phosphatase, however, was significantly higher in patients suffering from active colonic disease. Furthermore, the alkaline phosphatase in symptomatic patients was higher than that seen in a matched cohort undergoing OLT for chronic active hepatitis or primary biliary cirrhosis. These results suggest that (1) liver replacement and immunosuppression in patients suffering from sclerosing cholangitis and ulcerative colitis do not alter the course of the colon disease, and (2) active chronic ulcerative colitis does not adversely affect allograft function, although elevation of alkaline phosphatase may be the harbinger of recurrence over the long term.

Full text

PDF
598

Images in this article

600FIG. 1.
on p.600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cangemi J. R., Wiesner R. H., Beaver S. J., Ludwig J., MacCarty R. L., Dozois R. R., Zinsmeister A. R., LaRusso N. F. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology. 1989 Mar;96(3):790–794. [PubMed] [Google Scholar]
  2. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Das K. M., Vecchi M., Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology. 1990 Feb;98(2):464–469. doi: 10.1016/0016-5085(90)90839-s. [DOI] [PubMed] [Google Scholar]
  4. Dordal E., Glagov S., Kirsner J. B. Hepatic lesions in chronic inflammatory bowel disease. I. Clinical correlations with liver biopsy diagnoses in 103 patients. Gastroenterology. 1967 Feb;52(2):239–253. [PubMed] [Google Scholar]
  5. Duerr R. H., Targan S. R., Landers C. J., LaRusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1385–1391. [PubMed] [Google Scholar]
  6. Eade M. N., Cooke W. T., Brooke B. N. Liver disease in ulcerative colitis. II. The long-term effect of colectomy. Ann Intern Med. 1970 Apr;72(4):489–497. doi: 10.7326/0003-4819-72-4-489. [DOI] [PubMed] [Google Scholar]
  7. LaRusso N. F., Wiesner R. H., Ludwig J., MacCarty R. L. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984 Apr 5;310(14):899–903. doi: 10.1056/NEJM198404053101407. [DOI] [PubMed] [Google Scholar]
  8. Lennard-Jones J. E. Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease. Gut. 1983 Mar;24(3):177–181. doi: 10.1136/gut.24.3.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lichtiger S., Present D. H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet. 1990 Jul 7;336(8706):16–19. doi: 10.1016/0140-6736(90)91521-b. [DOI] [PubMed] [Google Scholar]
  10. Lindor K. D., Wiesner R. H., LaRusso N. F., Homburger H. A. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology. 1987 Sep-Oct;7(5):884–888. doi: 10.1002/hep.1840070515. [DOI] [PubMed] [Google Scholar]
  11. Lindor K. D., Wiesner R. H., MacCarty R. L., Ludwig J., LaRusso N. F. Advances in primary sclerosing cholangitis. Am J Med. 1990 Jul;89(1):73–80. doi: 10.1016/0002-9343(90)90101-i. [DOI] [PubMed] [Google Scholar]
  12. MISTILIS S. P., SKYRING A. P., GOULSTON S. J. PERICHOLANGITIS AND ULCERATIVE COLITIS. II. CLINICAL ASPECTS. Ann Intern Med. 1965 Jul;63:17–26. doi: 10.7326/0003-4819-63-1-17. [DOI] [PubMed] [Google Scholar]
  13. Marsh J. W., Jr, Iwatsuki S., Makowka L., Esquivel C. O., Gordon R. D., Todo S., Tzakis A., Miller C., Van Thiel D., Starzl T. E. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg. 1988 Jan;207(1):21–25. doi: 10.1097/00000658-198801000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Minuk G. Y., Angus M., Brickman C. M., Lawley T. J., Frank M. M., Hoofnagle J. H., Jones E. A. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology. 1985 Jan;88(1 Pt 1):166–170. doi: 10.1016/s0016-5085(85)80149-9. [DOI] [PubMed] [Google Scholar]
  15. Podolsky D. K. Inflammatory bowel disease (2) N Engl J Med. 1991 Oct 3;325(14):1008–1016. doi: 10.1056/NEJM199110033251406. [DOI] [PubMed] [Google Scholar]
  16. Rabinovitz M., Gavaler J. S., Schade R. R., Dindzans V. J., Chien M. C., Van Thiel D. H. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology. 1990 Jan;11(1):7–11. doi: 10.1002/hep.1840110103. [DOI] [PubMed] [Google Scholar]
  17. Wood R. A., Cuschieri A. Is sclerosing cholangitis complicating ulcerative colitis a reversible condition? Lancet. 1980 Oct 4;2(8197):716–718. doi: 10.1016/s0140-6736(80)91935-2. [DOI] [PubMed] [Google Scholar]
  18. Zajko A. B., Campbell W. L., Logsdon G. A., Bron K. M., Tzakis A., Esquivel C. O., Starzl T. E. Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol. 1987 Sep;149(3):485–489. doi: 10.2214/ajr.149.3.485. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES